February 28, 2022
Supporting Health Equity for All Through Leadership, Action and Partnership
"Health equity" means that everyone has a fair and just opportunity to live the healthiest life possible, regardless of who they are, where they live or how...
Read More ›
December 21, 2021
Alnylam Publishes 2021 Patient Access Philosophy Report
Alnylam has published its 2021 Patient Access Philosophy Report detailing its actions as a company to provide access to its medicines for those who may...
Read More ›
December 16, 2021
Guest Post: Creating Connections to Support the hATTR Amyloidosis Community
Susanne Berglund is the Chancellor of FAMY Norrbotten, an amyloidosis patient advocacy group reflects on the importance of making connections to support...
Read More ›
September 6, 2021
Co-Creating with Patients, for Patients: Addressing Unmet Needs in Conversations about AT ...
Collaborating with patient organizations and patients is an essential part of our efforts to support people living with a complex rare disease like...
Read More ›
September 4, 2021
Guest Post: Tracking My hATTR Amyloidosis Symptoms to Take Back Control
David, from the UK, is living with hereditary ATTR amyloidosis. In this article, he discusses how he's using the STAR Symptom Tracker App to track his symptoms
Read More ›
April 15, 2021
Guest Post: Partnering to Make a Positive Difference for People with Kidney Disease
LaVarne Burton, President and CEO of the American Kidney Fund talks about the importance of partnerships...
Read More ›
March 12, 2021
Decades of Pain and Uncertainty: Donna’s AHP Story
For more than 20 years, Donna navigated debilitating pain, mysterious symptoms and uncertainty about her health. Today, with a better handle on her wellbeing...
Read More ›
March 2, 2021
When Are Kidney Stones a Red Flag?
According to some estimates, every 1 in 10 adults in the U.S. experiences a kidney stone, suggesting that kidney stones can be rather prevalent. But when are...
Read More ›
February 23, 2021
Rare Disease Day 2021: Rare Is Many. Rare Is Strong. Rare Is Proud.
While some aspects of living with a rare disease are similar, there is no singular shared experience. There is, however, a common sentiment among those...
Read More ›
December 7, 2020
Alnylam Releases 2nd Annual Patient Access Philosophy Report
The 2020 Alnylam Patient Access Philosophy Report details Alnylam's progress against key metrics related to patient access to its innovative RNAi therapeutics.
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site